Divis Laboratories Fact Sheet, Divis Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Fact Sheet    (DIVI)


UNLOCKED: Up to 3x More Gains During the Corona Crisis...


Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

DIVIS LABORATORIES Price History

Price Rs 3,085.7
Mkt Cap Rs m 819,141
Vol '000 17.1
P/E X 51.1
P/CF X 53.8
EPS (TTM) Rs 60.3
% ch % 0.3
No. of shares m 265.47
% ch week % -1.4
% ch 1-mth % -2.3
% ch 12-mth % 77.1
52 week H/L Rs 3,388.0/1,627.2
(As on Oct 22, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DIVIS LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
DIVIS LABORATORIES EQUITY SHARE DATA
High Rs1,8812,4841,2221,1421,639 
Low Rs1,2179187845331,115 
Sales per share (Unadj.) Rs234.7142.3153.1146.6186.3 
Earnings per share (Unadj.) Rs64.242.439.933.051.0 
Diluted earnings per shareRs32.142.439.933.051.0 
Cash flow per share (Unadj.) Rs74.446.944.638.457.3 
Dividends per share (Unadj.) Rs20.0010.0010.0010.0016.00 
Adj. dividends per shareRs10.0010.0010.0010.0016.00 
Dividend yield (eoy) %1.30.61.01.21.2 
Book value per share (Unadj.) Rs288.0161.7201.8222.8261.8 
Adj. book value per shareRs144.0161.7201.8222.8261.8 
Shares outstanding (eoy) m132.73265.47265.47265.47265.47 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x6.612.06.65.77.4 
Avg P/E ratio x24.140.125.125.327.0 
P/CF ratio (eoy) x20.836.322.521.824.0 
Price / Book Value ratio x5.410.55.03.85.3 
Dividend payout %31.223.625.030.331.4 
Avg Mkt Cap Rs m205,599451,525266,266222,318365,592 
No. of employees `0008.79.59.710.811.8 
Total wages/salary Rs m2,9043,6124,9994,5615,423 
Avg. sales/employee Rs Th3,571.83,983.14,175.03,616.04,175.1 
Avg. wages/employee Rs Th333.0381.0513.5423.8457.7 
Avg. net profit/employee Rs Th976.41,187.41,089.3814.91,141.8 
DIVIS LABORATORIES INCOME DATA
Net Sales Rs m31,14937,76440,64338,91549,463 
Other income Rs m4479747491,1341,556 
Total revenues Rs m31,59638,73841,39240,04951,019 
Gross profit Rs m11,65214,17414,46012,61718,718 
Depreciation Rs m1,3601,1821,2331,4251,689 
Interest Rs m1938231335 
Profit before tax Rs m10,72113,92813,95312,31318,551 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,2062,6713,3493,5435,023 
Profit after tax Rs m8,51511,25810,6048,77013,527 
Gross profit margin %37.437.535.632.437.8 
Effective tax rate %20.619.224.028.827.1 
Net profit margin %27.329.826.122.527.3 
DIVIS LABORATORIES BALANCE SHEET DATA
Current assets Rs m27,72430,27040,10545,35146,501 
Current liabilities Rs m4,5605,1956,5956,5348,468 
Net working cap to sales %74.466.482.599.776.9 
Current ratio x6.15.86.16.95.5 
Inventory Days Days136117119127131 
Debtors Days Days8785819586 
Net fixed assets Rs m15,23116,99819,99521,16025,797 
Share capital Rs m266531531531531 
"Free" reserves Rs m37,95842,40253,04358,62568,962 
Net worth Rs m38,22342,93353,57459,15669,493 
Long term debt Rs m115000 
Total assets Rs m43,82949,02161,58567,85980,383 
Interest coverage x577.4369.5618.4926.8531.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.80.70.60.6 
Return on assets %19.523.017.312.916.9 
Return on equity %22.326.219.814.819.5 
Return on capital %28.132.526.120.826.7 
Exports to sales %84.385.3000 
Imports to sales %23.922.925.221.824.6 
Exports (fob) Rs m26,24432,198000 
Imports (cif) Rs m7,4428,65410,2608,48512,187 
Fx inflow Rs m26,31732,27035,38432,35941,238 
Fx outflow Rs m7,5888,77510,3999,04212,405 
Net fx Rs m18,72923,49624,98523,31728,833 
DIVIS LABORATORIES CASH FLOW
From Operations Rs m 8,263 10,379 11,504 7,759 9,543 
From Investments Rs m -5,208 -4,064 -11,396 -4,783 -6,854 
From Financial Activity Rs m -3,030 -6,311 24 -3,142 -2,459 
Net Cashflow Rs m 25 3 132 -166 230 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 52.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.8%
FIIs 19.0%
ADR/GDR 0.0%
Free float 17.2%
Shareholders 31,796
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 7-1-77/E/1/303, Divi Towers, Dharam Karan Road, Ameerpet, Hyderabad-16
E-MAIL cs@divislaboratories.com WEB www.divislaboratories.com
TELEPHONE (040) 2378 6300 FAX (040) 2378 6460
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR P. V. R. K. Nageswara Rao & Co.
CHM: Murali K. Divi (MD) COMP SEC: P. V. Lakshmi Rajani YEAR OF INC: 1990 BSE CODE: 532488 FV (Rs): 2 DIV YIELD (%): 0.5

Read: DIVIS LABORATORIES 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUVEN LIFESCIENCES  PROCTER & GAMBLE HEALTH  J.B.CHEMICALS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare DIVIS LABORATORIES With:   SUVEN LIFESCIENCES  PROCTER & GAMBLE HEALTH  J.B.CHEMICALS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; Smallcap Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended marginally lower.

Views on news

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - TEVA PHARMA COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS